Cite
Letter frequency analysis of proprietary prescription drug names in the United States: Minding the Zs and Qs
MLA
Ron Carico, Jr, et al. “Letter Frequency Analysis of Proprietary Prescription Drug Names in the United States: Minding the Zs and Qs.” Exploratory Research in Clinical and Social Pharmacy, vol. 6, no. 100146-, June 2022. EBSCOhost, https://doi.org/10.1016/j.rcsop.2022.100146.
APA
Ron Carico, J., Keaton Kaplan, Kyler Gator Hazelett, Megan Dillon, & Kelly Melvin. (2022). Letter frequency analysis of proprietary prescription drug names in the United States: Minding the Zs and Qs. Exploratory Research in Clinical and Social Pharmacy, 6(100146-). https://doi.org/10.1016/j.rcsop.2022.100146
Chicago
Ron Carico, Jr, Keaton Kaplan, Kyler Gator Hazelett, Megan Dillon, and Kelly Melvin. 2022. “Letter Frequency Analysis of Proprietary Prescription Drug Names in the United States: Minding the Zs and Qs.” Exploratory Research in Clinical and Social Pharmacy 6 (100146-). doi:10.1016/j.rcsop.2022.100146.